Professor | Yuanfei Zhu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yuanfei Zhu
Contact Information	nzhuyuanfei@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Yuanfei Zhu

Contact Information

nzhuyuanfei@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2014-09 to 2017-07, PhD in Integrated Chinese and Western Medicine Clinical, Shanghai University of Traditional Chinese Medicine 2006-07 to 2008-07, Master's in Chinese Medicine, Shanghai University of Traditional Chinese Medicine 2001-09 to 2006-07, Bachelor's in Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Work Experience	2017-07 to 2021-11, Fudan University, School of Basic Medical Sciences, Department of Pathogen Biology, Postdoctoral Researcher 2008-07 to 2014-08, Pfizer Investment Co., Ltd., Cardiovascular Division, Medical Information Communication Specialist

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2014-09 to 2017-07, PhD in Integrated Chinese and Western Medicine Clinical, Shanghai University of Traditional Chinese Medicine
2006-07 to 2008-07, Master's in Chinese Medicine, Shanghai University of Traditional Chinese Medicine
2001-09 to 2006-07, Bachelor's in Chinese Medicine, Shanghai University of Traditional Chinese Medicine

Work Experience

2017-07 to 2021-11, Fudan University, School of Basic Medical Sciences, Department of Pathogen Biology, Postdoctoral Researcher
2008-07 to 2014-08, Pfizer Investment Co., Ltd., Cardiovascular Division, Medical Information Communication Specialist

Areas of Focus	Basic research on viral infections and antiviral drugs
Publications	Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection, Zang, Jinkai; Zhu, Yuanfei; Zhou, Yu; Gu, Chenjian; Yi, Yufang; Wang, Shuxia; Xu, Shiqi; Hu, Gaowei; Du, Shujuan; Yin, Yannan; Wang, Yalei; Yang, Yong; Zhang, Xueyang; Wang, Haikun; Yin, Feifei; Zhang, Chao; Deng, Qiang; Xie, Youhua; Huang, Zhong, 2021 Application of micro-ring DNA technology to induce and prepare recombinant covalently closed circular DNA of hepatitis B virus in vitro, Zhu, Yuanfei; Li, Gaiyun; Chang, Hao; Yu, Kangkang; Gao, Yueqiu; Deng, Qiang, 2017 Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2, Gu, Chenjian; Wu, Yang; Guo, Huimin; Zhu, Yuanfei; Xu, Wei; Wang, Yuyan; Zhou, Yu; Sun, Zhiping; Cai, Xia; Li, Yutang; Liu, Jing; Huang, Zhong; Yuan, Zhenghong; Zhang, Rong; Deng, Qiang; Qu, Di; Xie, Youhua, 2021 Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections, Zhang, Chao; Wang, Yifan; Zhu, Yuanfei; Liu, Caixuan; Gu, Chenjian; Xu, Shiqi; Wang, Yalei; Zhou, Yu; Wang, Yanxing; Han, Wenyu; Hong, Xiaoyu; Yang, Yong; Zhang, Xueyang; Wang, Tingfeng; Xu, Cong; Hong, Qin; Wang, Shutian; Zhao, Qiaoyu; Qiao, Weihua; Zang, Jinkai; Kong, Liangliang; Wang, Fangfang; Wang, Haikun; Qu, Di; Lavillette, Dimitri; Tang, Hong; Deng, Qiang; Xie, Youhua; Cong, Yao; Huang, Zhong, 2021 A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants, Zhenlin Yang; Yulu Wang; Yujia Jin; Yuanfei Zhu; Yanling Wu; Cheng Li; Yu Kong; Wenping Song; Xiaolong Tian; Wuqiang Zhan; Ailing Huang; Shanshan Zhou; Shuai Xia; Xiaoxu Tian; Chao Peng; Cuicui Chen; Yibing Shi; Gaowei Hu; Shujuan Du; Yuyan Wang; Youhua Xie; Shibo Jiang; Lu Lu; Lei Sun; Yuanlin Song; Tianlei Ying, 2021

Areas of Focus

Basic research on viral infections and antiviral drugs

Publications

Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection, Zang, Jinkai; Zhu, Yuanfei; Zhou, Yu; Gu, Chenjian; Yi, Yufang; Wang, Shuxia; Xu, Shiqi; Hu, Gaowei; Du, Shujuan; Yin, Yannan; Wang, Yalei; Yang, Yong; Zhang, Xueyang; Wang, Haikun; Yin, Feifei; Zhang, Chao; Deng, Qiang; Xie, Youhua; Huang, Zhong, 2021
Application of micro-ring DNA technology to induce and prepare recombinant covalently closed circular DNA of hepatitis B virus in vitro, Zhu, Yuanfei; Li, Gaiyun; Chang, Hao; Yu, Kangkang; Gao, Yueqiu; Deng, Qiang, 2017
Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2, Gu, Chenjian; Wu, Yang; Guo, Huimin; Zhu, Yuanfei; Xu, Wei; Wang, Yuyan; Zhou, Yu; Sun, Zhiping; Cai, Xia; Li, Yutang; Liu, Jing; Huang, Zhong; Yuan, Zhenghong; Zhang, Rong; Deng, Qiang; Qu, Di; Xie, Youhua, 2021
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections, Zhang, Chao; Wang, Yifan; Zhu, Yuanfei; Liu, Caixuan; Gu, Chenjian; Xu, Shiqi; Wang, Yalei; Zhou, Yu; Wang, Yanxing; Han, Wenyu; Hong, Xiaoyu; Yang, Yong; Zhang, Xueyang; Wang, Tingfeng; Xu, Cong; Hong, Qin; Wang, Shutian; Zhao, Qiaoyu; Qiao, Weihua; Zang, Jinkai; Kong, Liangliang; Wang, Fangfang; Wang, Haikun; Qu, Di; Lavillette, Dimitri; Tang, Hong; Deng, Qiang; Xie, Youhua; Cong, Yao; Huang, Zhong, 2021
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants, Zhenlin Yang; Yulu Wang; Yujia Jin; Yuanfei Zhu; Yanling Wu; Cheng Li; Yu Kong; Wenping Song; Xiaolong Tian; Wuqiang Zhan; Ailing Huang; Shanshan Zhou; Shuai Xia; Xiaoxu Tian; Chao Peng; Cuicui Chen; Yibing Shi; Gaowei Hu; Shujuan Du; Yuyan Wang; Youhua Xie; Shibo Jiang; Lu Lu; Lei Sun; Yuanlin Song; Tianlei Ying, 2021

Viral Infections Antiviral Drugs Basic Research Hepatitis B Car-T Strategy Chronic Gastritis Metabolites Diagnostic Model Autophagy Interferon Pathways

Yuchen Xia - Wuhan University

Jiangxia Liu - Fudan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us